Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1180573

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1180573

Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Report 2022

PUBLISHED:
PAGES: 171 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3350
PDF (Multi User License)
USD 5025
PDF (Enterprise User License)
USD 6700

Add to Cart

Market Analysis and Insights:

Due to the COVID-19 pandemic, the Europe and United States Prothrombin Complex Concentrate (PCC) Drug market size is estimated to be worth US$ 674.7 million in 2022 and is forecast to a readjusted size of US$ 1314.68 million by 2028 with a CAGR of 11.76% during the review period. Fully considering the economic change by this health crisis, Beriplex accounting for 68.2% of the Prothrombin Complex Concentrate (PCC) Drug Europe and United States market in 2021, is projected to value US$ 887 million by 2028, growing at a revised 11.52% CAGR in the post-COVID-19 period.

In Europe and United States, the key manufacturers of Prothrombin Complex Concentrate (PCC) Drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, and Takeda. In 2021, the Europe and United States top five players have a share approximately 98% in terms of revenue.

Scope and Segment:

Prothrombin Complex Concentrate (PCC) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the Europe and United States Prothrombin Complex Concentrate (PCC) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

By Company

  • CSL Behring
  • Grifols
  • Octapharma
  • Prothya Biosolutions
  • Takeda

Segment by Type

  • Beriplex
  • Profilnine
  • Octaplex
  • Prothromplex
  • Cofact
  • Other

Segment by Application

  • Hemophilia B
  • Acquired Coagulation Factor Deficiency
  • Others

Segment by Country/Region

  • United States
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherland
  • Other Countries

TABLE OF CONTENTS

1 STUDY COVERAGE

  • 1.1 Prothrombin Complex Concentrate (PCC) Drug Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Cofact
    • 1.2.3 Beriplex
    • 1.2.4 Profilnine
    • 1.2.5 Octaplex
    • 1.2.6 Prothromplex
  • 1.3 Market by Application
    • 1.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Hemophilia B
    • 1.3.3 Acquired Coagulation Factor Deficiency
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 EXECUTIVE SUMMARY

  • 2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Estimates and Forecasts 2017-2028
  • 2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Estimates and Forecasts 2017-2028
  • 2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2017 VS 2021 VS 2028
  • 2.4 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country
    • 2.4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022)
    • 2.4.2 Europe and United States Sales Prothrombin Complex Concentrate (PCC) Drug by Country (2023-2028)
  • 2.5 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country
    • 2.5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022)
    • 2.5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2023-2028)
  • 2.6 Germany
  • 2.7 France
  • 2.8 UK
  • 2.9 Italy
  • 2.10 Spain
  • 2.11 Netherland
  • 2.12 United States
  • 2.13 Other Countries

3 COMPETITION BY MANUFACTURERS

  • 3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers
    • 3.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2017-2022)
    • 3.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Europe and United States Top Largest Manufacturers of Prothrombin Complex Concentrate (PCC) Drug in 2021
  • 3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers
    • 3.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers (2017-2022)
    • 3.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Europe and United States Top Companies by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2021
  • 3.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

  • 4.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type
    • 4.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Type (2017-2022)
    • 4.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Type (2023-2028)
    • 4.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • 4.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type
    • 4.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Type (2017-2022)
    • 4.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • 4.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type
    • 4.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2022)
    • 4.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2023-2028)

5 MARKET SIZE BY APPLICATION

  • 5.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application
    • 5.1.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Sales by Application (2017-2022)
    • 5.1.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Sales by Application (2023-2028)
    • 5.1.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • 5.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application
    • 5.2.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Historical Revenue by Application (2017-2022)
    • 5.2.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • 5.3 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application
    • 5.3.1 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2022)
    • 5.3.2 Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2023-2028)

6 GERMANY

  • 6.1 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 6.1.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 6.1.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 6.2 Germany Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 6.2.1 Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 6.2.2 Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

7 FRANCE

  • 7.1 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 7.1.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 7.1.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 7.2 France Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 7.2.1 France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 7.2.2 France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

8 UK

  • 8.1 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 8.1.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 8.1.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 8.2 UK Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 8.2.1 UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 8.2.2 UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

9 ITALY

  • 9.1 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 9.1.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 9.1.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 9.2 Italy Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 9.2.1 Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 9.2.2 Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

10 SPAIN

  • 10.1 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 10.1.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 10.1.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 10.2 Spain Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 10.2.1 Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 10.2.2 Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

11 NETHERLAND

  • 11.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 11.1.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 11.1.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 11.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 11.2.1 Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 11.2.2 Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

12 UNITED STATES

  • 12.1 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 12.1.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 12.1.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 12.2 United States Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 12.2.1 United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 12.2.2 United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

13 OTHER COUNTRIES

  • 13.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Type
    • 13.1.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2028)
    • 13.1.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2028)
  • 13.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Market Size by Application
    • 13.2.1 Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2028)
    • 13.2.2 Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2028)

14 CORPORATE PROFILE

  • 14.1 CSL Behring
    • 14.1.1 CSL Behring Corporation Information
    • 14.1.2 CSL Behring Overview
    • 14.1.3 CSL Behring in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
    • 14.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 14.1.5 CSL Behring Recent Developments
  • 14.2 Grifols
    • 14.2.1 Grifols Corporation Information
    • 14.2.2 Grifols Overview
    • 14.2.3 Grifols in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
    • 14.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 14.2.5 Grifols Recent Developments
  • 14.3 Octapharma
    • 14.3.1 Octapharma Corporation Information
    • 14.3.2 Octapharma Overview
    • 14.3.3 Octapharma in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
    • 14.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 14.3.5 Octapharma Recent Developments
  • 14.4 Prothya Biosolutions
    • 14.4.1 Prothya Biosolutions Corporation Information
    • 14.4.2 Prothya Biosolutions Overview
    • 14.4.3 Prothya Biosolutions in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
    • 14.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • 14.5 Takeda
    • 14.5.1 Takeda Corporation Information
    • 14.5.2 Takeda Overview
    • 14.5.3 Takeda in Europe and United States: Prothrombin Complex Concentrate (PCC) Drug Sales, Price, Revenue and Gross Margin (2017-2022)
    • 14.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
    • 14.5.5 Takeda Recent Developments

15 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

  • 15.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain Analysis
  • 15.2 Prothrombin Complex Concentrate (PCC) Drug Key Raw Materials
    • 15.2.1 Key Raw Materials
    • 15.2.2 Raw Materials Key Suppliers
  • 15.3 Prothrombin Complex Concentrate (PCC) Drug Production Mode & Process
  • 15.4 Prothrombin Complex Concentrate (PCC) Drug Sales and Marketing
    • 15.4.1 Prothrombin Complex Concentrate (PCC) Drug Sales Channels
    • 15.4.2 Prothrombin Complex Concentrate (PCC) Drug Distributors
  • 15.5 Prothrombin Complex Concentrate (PCC) Drug Customers

16 PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG MARKET DYNAMICS

    • 16.1.1 Prothrombin Complex Concentrate (PCC) Drug Industry Trends
    • 16.1.2 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
    • 16.1.3 Prothrombin Complex Concentrate (PCC) Drug Market Challenges
    • 16.1.4 Prothrombin Complex Concentrate (PCC) Drug Market Restraints

17 KEY FINDINGS IN THE EUROPE AND UNITED STATES PROTHROMBIN COMPLEX CONCENTRATE (PCC) DRUG STUDY

18 APPENDIX

  • 18.1 Research Methodology
    • 18.1.1 Methodology/Research Approach
    • 18.1.2 Data Source
  • 18.2 Author Details
  • 18.3 Disclaimer

LIST OF TABLES

  • Table 1. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Beriplex
  • Table 3. Major Manufacturers of Profilnine
  • Table 4. Major Manufacturers of Octaplex
  • Table 5. Major Manufacturers of Prothromplex
  • Table 6. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 8. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2017-2022) & (K Units)
  • Table 9. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)
  • Table 10. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Country (2023-2028) & (K Units)
  • Table 11. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2023-2028)
  • Table 12. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2017-2022) & (US$ Million)
  • Table 13. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2017-2022)
  • Table 14. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Country (2023-2028) & (US$ Million)
  • Table 15. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country (2023-2028)
  • Table 16. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Manufacturers (2017-2022) & (K Units)
  • Table 17. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Manufacturers (2017-2022)
  • Table 18. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 19. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Manufacturers (2017-2022)
  • Table 20. Prothrombin Complex Concentrate (PCC) Drug Price by Manufacturers (2017-2022) & (US$/Unit)
  • Table 21. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Europe and United States Prothrombin Complex Concentrate (PCC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prothrombin Complex Concentrate (PCC) Drug as of 2021)
  • Table 23. Prothrombin Complex Concentrate (PCC) Drug Manufacturing Base Distribution and Headquarters
  • Table 24. Manufacturers Prothrombin Complex Concentrate (PCC) Drug Product Offered
  • Table 25. Founded Date of Prothrombin Complex Concentrate (PCC) Drug Manufacturer
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 28. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 29. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2017-2022)
  • Table 30. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Type (2023-2028)
  • Table 31. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 32. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 33. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2017-2022)
  • Table 34. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Type (2023-2028)
  • Table 35. Prothrombin Complex Concentrate (PCC) Drug Price by Type (2017-2022) & (US$/Unit)
  • Table 36. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Type (2023-2028) & (US$/Unit)
  • Table 37. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 38. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 39. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2017-2022)
  • Table 40. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Share by Application (2023-2028)
  • Table 41. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 42. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 43. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2017-2022)
  • Table 44. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Share by Application (2023-2028)
  • Table 45. Prothrombin Complex Concentrate (PCC) Drug Price by Application (2017-2022) & (US$/Unit)
  • Table 46. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Price Forecast by Application (2023-2028) & (US$/Unit)
  • Table 47. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 48. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 49. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 50. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 51. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 52. Germany Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 53. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 54. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 55. France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 56. France Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 57. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 58. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 59. France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 60. France Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 61. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 62. France Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 63. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 64. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 65. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 66. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 67. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 68. UK Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 69. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 70. UK Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 71. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 72. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 73. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 74. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 75. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 76. Italy Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 77. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 78. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 79. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 80. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 81. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 82. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 83. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 84. Spain Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 85. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 86. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 87. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 88. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 89. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 90. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 91. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 92. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 93. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 94. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 95. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 96. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 97. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 98. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 99. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 100. United States Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 101. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 102. United States Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 103. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2017-2022) & (K Units)
  • Table 104. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Type (2023-2028) & (K Units)
  • Table 105. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2017-2022) & (US$ Million)
  • Table 106. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Type (2023-2028) & (US$ Million)
  • Table 107. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2017-2022) & (K Units)
  • Table 108. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales by Application (2023-2028) & (K Units)
  • Table 109. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2017-2022) & (US$ Million)
  • Table 110. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue by Application (2023-2028) & (US$ Million)
  • Table 111. CSL Behring Corporation Information
  • Table 112. CSL Behring Description and Major Businesses
  • Table 113. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 114. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. CSL Behring Recent Developments
  • Table 116. Grifols Corporation Information
  • Table 117. Grifols Description and Major Businesses
  • Table 118. Grifols Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 119. Grifols Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Grifols Recent Developments
  • Table 121. Octapharma Corporation Information
  • Table 122. Octapharma Description and Major Businesses
  • Table 123. Octapharma Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 124. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Octapharma Recent Developments
  • Table 126. Prothya Biosolutions Corporation Information
  • Table 127. Prothya Biosolutions Description and Major Businesses
  • Table 128. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 129. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Takeda Corporation Information
  • Table 131. Takeda Description and Major Businesses
  • Table 132. Takeda Prothrombin Complex Concentrate (PCC) Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
  • Table 133. Takeda Prothrombin Complex Concentrate (PCC) Drug Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 134. Takeda Recent Developments
  • Table 135. Key Raw Materials Lists
  • Table 136. Plasma: Cost Components
  • Table 137. Raw Materials Key Suppliers Lists
  • Table 138. Prothrombin Complex Concentrate (PCC) Drug Distributors List
  • Table 139. Prothrombin Complex Concentrate (PCC) Drug Customers List
  • Table 140. Prothrombin Complex Concentrate (PCC) Drug Market Trends
  • Table 141. Key Transactions in the Blood Plasma Fractionation Industry 1997'2019 (Market Trends)
  • Table 142. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
  • Table 143. Prothrombin Complex Concentrate (PCC) Drug Market Challenges
  • Table 144. Prothrombin Complex Concentrate (PCC) Drug Market Restraints
  • Table 145. Research Programs/Design for This Report
  • Table 146. Key Data Information from Secondary Sources
  • Table 147. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Prothrombin Complex Concentrate (PCC) Drug Product Picture
  • Figure 2. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Type, 2017-2028 (US$ Million)
  • Figure 3. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2021
  • Figure 4. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Type: 2028
  • Figure 5. Cofact Product Picture
  • Figure 6. Major Manufacturers of Cofact
  • Figure 7. Beriplex Product Picture
  • Figure 8. Profilnine Product Picture
  • Figure 9. Octaplex Product Picture
  • Figure 10. Prothromplex Product Picture
  • Figure 11. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Size Growth Rate by Application, 2017-2028 (US$ Million)
  • Figure 12. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2021
  • Figure 13. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Market Share by Application: 2028
  • Figure 14. Hemophilia B
  • Figure 15. Prothrombin Complex Concentrate (PCC) Drug Report Years Considered
  • Figure 16. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales 2017-2028 (K Units)
  • Figure 17. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
  • Figure 18. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue 2017-2028 (US$ Million)
  • Figure 19. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in Percentage: 2021
  • Figure 20. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Country in Percentage: 2028
  • Figure 21. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2017-2022)
  • Figure 22. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Country (2023-2028)
  • Figure 23. Germany Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 24. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 25. France Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 26. France Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 27. UK Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 28. UK Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 29. Italy Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 30. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 31. Spain Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 32. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 33. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 34. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 35. United States Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 36. United States Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 37. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales YoY (2017-2028) & (K Units)
  • Figure 38. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue YoY (2017-2028) & (US$ Million)
  • Figure 39. The Prothrombin Complex Concentrate (PCC) Drug Market Share of Top Largest Manufacturers in Europe and United States in 2021
  • Figure 40. The Top Largest Manufacturers of Prothrombin Complex Concentrate (PCC) Drug in Europe and United States: Market Share by Prothrombin Complex Concentrate (PCC) Drug Revenue in 2021
  • Figure 41. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 42. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 44. Europe and United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 45. Germany Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 46. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 47. Germany Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 48. Germany Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 49. France Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 50. France Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 51. France Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 52. France Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 53. UK Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 54. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 55. UK Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 56. UK Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 57. Italy Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 58. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 59. Italy Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 60. Italy Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 61. Spain Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 62. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 63. Spain Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 64. Spain Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 65. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 66. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 67. Netherland Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 68. Netherland Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 69. United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 70. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 71. United States Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 72. United States Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 73. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Type (2017-2028)
  • Figure 74. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Type (2017-2028)
  • Figure 75. Other Countries Prothrombin Complex Concentrate (PCC) Drug Sales Market Share by Application (2017-2028)
  • Figure 76. Other Countries Prothrombin Complex Concentrate (PCC) Drug Revenue Market Share by Application (2017-2028)
  • Figure 77. Prothrombin Complex Concentrate (PCC) Drug Value Chain
  • Figure 78. Diagram of Automated Plasma Collection Procedure
  • Figure 79. Manufacturing Process Analysis of Blood Plasma Fractionation
  • Figure 80. Main Product Separation Sequence of Blood Products during the Separation Process
  • Figure 81. Manufacturing Process Analysis of Prothrombin Complex Concentrate (PCC) Drug
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!